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S U M M A R Y
Objectives: The incidence of human granulocytic anaplasmosis (HGA), a tick-borne disease caused by the
obligate intracellular bacterium Anaplasma phagocytophilum, has increased across the world. However,
information on HGA is lacking in China. The purpose of this study was to investigate the clinical features
and outcomes of HGA patients in China.
Methods: A total of 83 patients with HGA from the provinces of Hubei and Henan in China, who were
admitted to Union Hospital between March 2009 and September 2010, were included in this study. We
investigated the epidemiology, clinical features, laboratory markers, and therapeutic effects in these
patients. We also analyzed life-threatening complications such as systemic inﬂammatory response
syndrome (SIRS)/multiple organ dysfunction syndrome (MODS) following HGA and assessed the risk
factors for a poor clinical outcome.
Results: In our study, an HGA outbreak peak was observed for the months May to August. The highest
age-speciﬁc incidence occurred among the group of patients aged 50–59 years. With regard to patient
occupation and pathological origin, we found that 73 of the 83 patients with HGA had a peasant
occupation. With respect to symptoms, 45 patients had no complications and 38 patients diagnosed with
HGA met SIRS criteria, of whom 25 rapidly developed MODS. The mortality for the entire cohort was
26.5%. The factors predictive of patients developing MODS and an adverse outcome were advanced age,
disturbance of consciousness, highly elevated lactate dehydrogenase, creatinine, and aspartate
aminotransferase levels, and the presence of SIRS. Moreover, MODS was found to be an independent
predictor of death.
Conclusions: In China, HGA patients had severe clinical symptoms and high rates of complications and
mortality. These ﬁndings may provide useful information so that physicians will be on the alert for
severe complications after a diagnosis of HGA; they will also be useful for optimizing supportive care for
HGA-related critical illness. Prompt treatment and close monitoring of severe complications such as SIRS
and MODS are of great importance in saving patient lives.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Human granulocytic anaplasmosis (HGA), formerly known as
human granulocytic ehrlichiosis (HGE), is a tick-borne disease
caused by the obligate intracellular bacterium Anaplasma phago-
cytophilum,1,2 which was ﬁrst reported in 1990.3 Since then, HGA
has become increasingly recognized and there have been reports
on HGA from the USA, Europe, and several other countries.2–5 In
2008, a case of nosocomial transmission of HGA occurred in China.6
A. phagocytophilum DNA has been detected in ticks on a global
scale, including in the countries of Israel, Japan, and China.7–9§ Huiyu Li and Yan Zhou contributed equally to this paper.
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doi:10.1016/j.ijid.2011.09.008Ixodes ticks act as vectors for A. phagocytophilum. The vector tick
species involved are Ixodes scapularis10 and Ixodes paciﬁcus in the
USA,11 and Ixodes ricinus in Europe;12 ticks involved in HGA are
present in Asia and the main vector tick species in China is Ixodes
persulcatus.9,13
Because the study of HGA in China was initiated only a couple of
years ago, knowledge and experience of the disease are limited. At
present this disease is not recognized by most doctors in China. The
diagnosis of HGA is difﬁcult since patients with HGA often present
with a non-speciﬁc febrile illness. The clinical manifestations of
HGA range from an asymptomatic illness to fatal disease. The
clinical manifestations and laboratory ﬁndings of HGA include
undifferentiated fever, headache, myalgias, thrombocytopenia,
and leukopenia, usually accompanied by elevations in the levels of
hepatic and cardiac enzymes.2,14 In China, the ﬁrst HGA case was
misdiagnosed as a hemorrhagic fever because the clinicalses. Published by Elsevier Ltd. All rights reserved.
Figure 1. The geographic distribution of human granulocytic anaplasmosis (HGA)
outbreaks in our cohort. The outbreaks were concentrated in the north of Hubei
Province and in the south of Henan Province from March 2009 to September 2010.
Numbers of cases are shown in brackets.
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commonly referred to as this disease. We found that the burden of
illness, clinical features, and outcomes differed greatly from those
in Western countries. More recently, the morbidity and mortality
associated with HGA in China has led to public health concern.
A better understanding of HGA and its related critical illness
may help to identify effective interventions for patients with HGA.
Hence, in this study, we investigated the epidemiology, clinical
features, laboratory ﬁndings, medical complications, treatment,
and outcome of 83 HGA patients who were admitted to the Union
Hospital, Huazhong University of Science and Technology in China.
2. Methods
2.1. Patients
We recorded and studied the epidemiological and clinical
information of a group of HGA patients at Union Hospital,
Huazhong University of Science and Technology over a consecutive
time-frame. A total of 83 patients from the provinces of Hubei and
Henan in China were hospitalized with HGA between March 2009
and September 2010. This disease seemed to occur as a small
epidemic outbreak. The following information was collected for
each patient: age, sex, occupation, location of residence, history of
animal contact and/or tick bite, and clinical features including date
of onset of symptoms, laboratory ﬁndings, medical complications,
treatments, and outcomes.
2.2. Diagnosis and monitoring of progress
As described in North America and Europe, all HGA patients
fulﬁlled the US Centers for Disease Control and Prevention (CDC)
laboratory criteria for the diagnosis of HGA.2,15,16
A probable case of HGA was deﬁned in patients with a clinically
compatible illness including epidemiology and typical manifesta-
tions similar to HGA or with one of the following results: a rise in
IgG titer to A. phagocytophilum or observation of morulae in
leukocytes.
A conﬁrmed case of anaplasmosis was deﬁned in patients with a
clinically compatible illness including epidemiology and typical
manifestations similar to HGA, with one of the following diagnostic
results: a four-fold change in antibody titer to Anaplasma species
antigen by indirect immunoﬂuorescence assay (IFA)17 in the acute
and recovery phase serum samples, or a positive polymerase chain
reaction (PCR) assay3 result, the visualization of morulae in white
blood cells, a single positive serum antibody titer by IFA, or
immunohistochemical staining (IHC) of an antigen in a tissue
biopsy, or isolation and culture of Anaplasma species.
Systemic inﬂammatory response syndrome (SIRS) represents a
state in which infections or other causes induce systemic
inﬂammatory reactions. Multiple organ dysfunction syndrome
(MODS) means that two or more organs are dysfunctional. Speciﬁc
criteria for the diagnosis of SIRS and MODS were applied. The
deﬁnition of SIRS was characterized by at least two of the following
four criteria: (1) fever or hypothermia, (2) tachycardia, (3)
tachypnea, and (4) leukocytosis or leukopenia.18 MODS was
deﬁned using the Marshall score.19
The majority of HGA patients had been treated with a
cephalosporin antibiotic at another hospital as a result of
misdiagnosis. However, once they were transferred to our hospital,
we were able to promptly provide empirical therapy with
doxycycline or rifampin to all patients who were suspected of
having HGA. At the same time, antibiotics of other spectrum were
also prescribed to prevent co-infections. In these patients there
was the potential for serious or even fatal conditions to develop if
these diseases were left untreated, especially in patients withimmunosuppressive conditions. Most patients responded to
treatment with doxycycline without complications.
2.3. Statistical analysis
The statistical analysis was performed using SPSS software
(version 17.0; SPSS, Chicago, IL, USA). Data are presented as mean
 standard deviation. The parameters considered at baseline,
including clinical and laboratory data, were analyzed using the
Student’s t-test and the Chi-square test. Correlations between
parameters and MODS were analyzed by Student’s t-test and binary
logistic regression. To determine the independent contributors to
MODS, those risk factors that proved to be signiﬁcant (p < 0.05) were
entered into a logistic regression model step by step for the
calculation of the relative risk as an odds ratio (OR) with 95%




The 83 patients with HGA in our hospital came from the mild
climate regions in the provinces of Hubei and Henan, regions
where several tick species have been identiﬁed. The patients were
residents of hilly land in northern Hubei Province including
Suizhou, Guangshui, suburbs of Wuhan, Macheng, Luotian,
Hong’an, Dawu, and Tongcheng and the hilly area of Xinyang City
in southern Henan Province and the urban areas of Xinyang,
Guangshan, Xinxian, Huangchuan, and Shangcheng. Most of these
areas feature the forests, mountains, and hills typical of central
China (Figure 1).
Thirty-one (37.3%) of the patients were male and 52 (62.7%)
were female; the male to female ratio was 1:1.68. Among the 83
patients, 73 (88.0%) had a peasant occupation, six were workers,
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During the study period, an HGA outbreak peak was observed for
the months of May to August (Figure 2A). The median patient
age was 52.5 years (range 18–78 years), and the highest age-
speciﬁc incidence occurred among those in the 50–59 years age
group (Figure 2B). With regard to survival status, the median age
of HGA patients who died was 57.6 years, of those who
improved was 51.5 years, and of those who recovered was 48.0
years (Figure 2C).
All patients had either been exposed to wild animals, had
labored in the ﬁeld, or had traveled in the suburbs in the 2 weeks
preceding the onset of initial symptoms. Only 21 symptomatic
patients recalled a recent tick bite prior to the onset of illness, and
we found a live tick in one patient. In other countries HGA has been
shown to spread among humans through vertical propagation and
blood.4,20 Also, nosocomial transmission of HGA through direct
contact with blood or respiratory secretions has been reported in
Anhui Province, China.4 Because our hospital practices standard
quarantine measures for patient relatives and medical personnel
with the use of equipment such as gloves, gowns, and masks, no
additional nosocomial outbreak of HGA was observed in our
hospital.
3.2. Diagnosis
Diagnosis was based on the epidemiology and typical clinical
manifestations and/or speciﬁc laboratory indices. In this study, 83
patients had epidemiological and clinical features typical of HGA.
Morulae in leukocytes were visualized in 12 cases. SerologicFigure 2. Bar charts showing the distribution of clinical cases of human granulocytic ana
mean patient age in relation to survival status. (A) Distribution of HGA cases by month of
consistent with the time distribution of active ticks. (B) The age distribution of patients
improved, and recovered (*p < 0.05, compared with the non-survival group).antibody (IgM or IgG) was positive in 69 cases, but a four-fold
change in antibody titer to Anaplasma species antigen obtained by
IFA in the acute-phase and convalescent-phase serum samples was
only obtained for 32 cases. Forty-nine cases were conﬁrmed by a
positive PCR assay result. In addition, we determined the positive
rates of IFA and PCR to be 83.1% and 59.0%, respectively. Finally, 59
(71.1%) conﬁrmed cases and 24 (28.9%) probable cases were
regarded as objective cases and analyzed together (Table 1).
Among the probable cases, it was too late to collect serum for
examination from 10 patients, but they were offered the empirical
antibiotic treatment. The majority of these patients died within a
short time as a result of their serious illness. For the remaining
probable cases, patient serum collection was carried out several
days after treatment, based on experience.
3.3. General presentation and monitoring of progress
The clinical presentation of HGA in our hospital varied in
severity from a mild, self-limiting illness to death. The main clinical
manifestations, including symptoms and signs are presented in
Table 2. Forty-ﬁve of the 83 HGA patients had no life-threatening
complications and infected patients recovered without developing
substantial clinical signs. However, 38 patients diagnosed with
HGA met SIRS criteria, of whom 25 rapidly developed MODS. This
disease affected many organ systems leading to disturbance of
consciousness (as a result of brain involvement), heart failure,
acute renal failure, hemorrhage, respiratory insufﬁciency or adult
respiratory distress syndrome (ARDS), and disseminated intravas-
cular coagulopathy (DIC).plasmosis (HGA) according to the month of onset and patient age at onset, and the
 illness onset. HGA outbreaks were mainly focused on the months of May to August,
 with HGA. (C) Mean patient age in the groups of patients who died (non-survival),
Table 1
Criteria for the diagnosis of HGA in the 83 study patients
Patients (n) Epidemiology and clinical manifestations Morulae IgM/IgG-positive IgG titer >4-fold PCR Diagnosis
10 + Probable
4 + + Probable
10 + + Probable
4 + + + Conﬁrmed
1 + + + + Conﬁrmed
2 + + + + Conﬁrmed
1 + + + + + Conﬁrmed
25 + + + + Conﬁrmed
5 + + + Conﬁrmed
21 + + + Conﬁrmed
HGA, human granulocytic anaplasmosis; PCR, polymerase chain reaction.
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status: those who survived and those who died. For those who
survived, the median time to visiting the doctors ofﬁce was 7 days
(range 2–15 days), median duration of the febrile period was 9
days (range 2–21 days), and the median number of hospital days
was 10 days (range 6–16 days); in the group of patients who died
these were 9 days (range 5–30 days), 10.5 days (range 6–30 days),
and 4 days (range 1–23 days), respectively.
3.4. Laboratory investigations
The most frequent laboratory abnormalities in patients with HGA
in our hospital are listed in Table 2. On hematological investigation,
white blood cell (WBC) counts were decreased in all patients, but to
varying degrees, and 42% had a WBC count between 1.1  109/l and
2.0  109/l (Figure 3A). Platelet (PLT) counts were also decreased,
and 50% had a PLT count of 21–50  109/l (Figure 3B). Alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) levels
were elevated, with 50% having an approximately 2–5-fold (81–200
U/l) increase in ALT (Figure 3C) and 42% having an approximately 5–
10-fold (201–400 U/l) increase in AST compared to the normal
reference values (Figure 3D). Although liver enzymes were elevated
in 76 cases, only two patients had a history of chronic liver disease.
The lactate dehydrogenase (LDH) level was 2–5-fold (501–1250 U/l)
higher compared to the normal value (Figure 3E) in 40% of patients,Table 2
The clinical manifestations and laboratory ﬁndings of patients with HGA in China
Clinical manifestations HGA patients, n (%) 
Fever 83 (100) 
Weakness 71 (85.5) 
Anorexia 64 (77.1) 
Nausea 44 (53.0) 
Diarrhea 43 (51.8) 
Chills 38 (45.8) 
Vomiting 33 (39.8) 
Cough 31 (37.3) 
Abdominal pain 30 (36.1) 
Myalgia 24 (28.9) 
Headache 18 (21.7) 
Oliguria 19 (22.9) 
Mental confusion 16 (19.3) 
Jaundice 14 (16.9) 
Expiratory dyspnea 10 (12.0) 
Melena 10 (12.0) 
Pulmonary disorder 27 (32.5) 
Abdominal tenderness 21 (25.3)
Inguinal lymph node enlargement 17 (20.5)
Skin ecchymosis 19 (22.9)
Ascites 9 (10.8)
HGA, human granulocytic anaplasmosis; AST, aspartate aminotransferase; ALT, a
thromboplastin time; CK, creatine kinase; CK-MB, creatine kinase-MB; BUN, blood urea
reactive protein.which suggests damage to tissues and organs with a low speciﬁcity.
A higher level of LDH serves as an important indicator for acute
myocardial infarction. Moreover, the activated partial thrombo-
plastin time (APTT) was recorded in 56 patients; APTT was slightly
prolonged (up to 63.6–93.5 s) in 29 cases and highly prolonged
(93.5 s) in 13 cases (Figure 3F).
3.5. Treatment and prognosis
Once the diagnosis was established as conﬁrmed or probable,
the patients without severe complications had excellent responses
to empirical antibiotic therapy with either doxycycline or rifampin.
In most patients, the temperature dropped to normal within 4
days, and the median length of doxycycline treatment was 6.5 days
(range 1–14 days). Although both leukopenia and thrombocyto-
penia were present in 96% of patients at initial presentation, these
abnormalities usually normalized after treatment of about 7 days.
After comprehensive treatment, serum parameters had greatly
improved or had recovered to normal levels in most patients. A
total of 61 patients (73.5%) were discharged: 37 (44.6%) had
improved and 24 (28.9%) had recovered. Fitness for discharge was
based on clinical signs and laboratory evidence of improvement in
patients. No obvious clinical sequelae were observed in those
patients who improved or recovered. The disease in patients with
advanced infections took longer to resolve.Laboratory ﬁndings HGA patients, n (%)
Leukopenia 83 (100)
Thrombocytopenia 77 (92.8)
Elevated serum AST 76 (91.6)
Elevated serum ALT 76 (91.6)
Elevated serum LDH 57 (68.7)
Extended serum APTT 56 (67.5)
Elevated serum CK 47 (56.6)
Elevated serum CK-MB 34 (41.0)
Elevated serum creatinine 23 (27.7)
Elevated serum BUN 26 (31.3)
Elevated FBG 23 (27.7)
Proteinuria (2+ to 4+) 61 (73.5)
Hematuria (2+ to 4+) 55 (66.3)
Elevated total bilirubin 20 (24.1)
Decreased total carbon dioxide 20 (24.1)
Elevated ESR 8 (9.6)
Elevated CRP 8 (9.6)
lanine aminotransferase; LDH, lactate dehydrogenase; APTT, activated partial
 nitrogen; FBG, fasting blood glucose; ESR, erythrocyte sedimentation rate; CRP, C-
Figure 3. Pie charts showing patient laboratory parameters in differentiated levels. (A) White blood cell count (WBC); (B) platelet count (PLT); (C) alanine aminotransferase
(ALT); (D) aspartate aminotransferase (AST); (E) lactate dehydrogenase (LDH); (F) activated partial thromboplastin time (APTT).
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16 who succumbed to MODS, four who died from circulatory
failure, one who died of ARDS, and one who died of DIC. Mortality
for the entire cohort was 26.5% (22/83). The average time between
the onset of symptoms and death was 25 days and that from
admission to hospital and death was 6 days.
3.6. The relationship between SIRS and MODS in patients with HGA
Interestingly, when we studied the entire cohort of hospital-
admitted HGA patients, more than 45.8% (38/83) met three or four
of the SIRS criteria, and a total of 25 cases met the MODS criteria.Figure 4. Venn diagram showing the relationship between systemic inﬂammatory
response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) in the
patient cohort. We compared SIRS with MODS by Chi-square test (Chi-square =
33.964, p = 0.000); next, we explored the relationship between SIRS and MODS
using binary logistic regression (OR, odds ratio; CI, conﬁdence interval).Eighteen patients met three of the SIRS criteria, and eight of them
developed MODS. Twenty patients met four of the SIRS criteria, and
13 of them developed MODS. Results show that the frequency rate
of MODS was as high as 30.1% (25/83) in HGA. These ﬁndings
suggest that, in our study, patients with HGA who met the
maximum number of SIRS criteria were at higher risk of
progressing to MODS. Mortality increased sequentially as more
SIRS criteria were met, rising to six cases when three SIRS criteria
were met and 14 cases when four criteria were met. We compared
SIRS with MODS by Chi-square test (Chi-square = 33.964,
p < 0.001). We also explored the relationship between SIRS and
MODS using binary logistic regression (OR 12.662, 95% CI 3.777–
42.441; Wald 16.922; p < 0.001) (Figure 4). Our ﬁndings showed
that SIRS was a risk factor for MODS, and that SIRS was a harbinger
of MODS in critically ill patients with HGA.
3.7. Factors predictive of MODS and death
All patients were divided into a MODS group and a non-MODS
group in order to estimate conditions related to the severity of
illness. By Student’s t-test we found that the following risk factors
were signiﬁcant predictors of MODS and the prognosis of HGA:
advanced age, a low-level WBC count, high AST, creatinine, blood
urea nitrogen (BUN), creatine kinase (CK), and LDH levels, and a
prolonged APTT (Table 3).
We then entered these risk factors into a logistic regression
model step by step. Finally, the results showed that the
independent predictors of MODS and an adverse outcome were
Table 3
Clinical and laboratory variables in HGA associated with MODS (mean  SD)
Variable HGA patients
without
MODS (n = 58)
HGA patients
with
MODS (n = 25)
p-Value
Age (years) 50.7  10.4 57.7  8.7 0.003a
Platelets (109/l) 35.8  20.7 31.9  27.4 0.525
WBC (109/l) 2.9  3.5 1.9  1.2 0.042a
APTT (s) 58.9  29.7 77.1  33.9 0.025a
BUN (mmol/l) 9.1  10.9 12.8  7.5 0.042a
Creatinine (mmol/l) 102.4  69.7 155.2  126.1 0.017a
AST (U/l) 585.6  1137.5 1209.5  1533.3 0.043a
ALT (U/l) 184.2  208.5 257.0  159.8 0.089
CK (U/l) 769.2  1369.3 1856.0  2381.0 0.010a
CK-MB (U/l) 31.2  35.2 46.0  36.5 0.222
LDH (U/l) 879.9  797.5 1814.8  1272.5 <0.01a
HGA, human granulocytic anaplasmosis; MODS, multiple organ dysfunction
syndrome; SD, standard deviation; WBC, white blood cell count; APTT, activated
partial thromboplastin time; BUN, blood urea nitrogen; AST, aspartate aminotrans-
ferase; ALT, alanine aminotransferase; CK, creatine kinase; CK-MB, creatine kinase-
MB; LDH, lactate dehydrogenase.
a p < 0.05, HGA patients without MODS group vs. HGA patients with MODS
group, by Student’s t-test.
Table 4
Predictors of MODS in HGA patients, analyzed by logistic regressiona
Variable OR 95% CI Wald p-Value
Age 2.115 0.99–4.519 3.738 0.053
AST 2.159 1.098–4.244 4.981 0.026
Creatinine 4.840 1.180–19.863 4.793 0.029
LDH 2.158 1.208–3.852 6.760 0.009
Disturbance of consciousness 8.846 3.193–24.512 17.575 0.000
MODS, multiple organ dysfunction syndrome; HGA, human granulocytic anaplas-
mosis; OR, odds ratio; CI, conﬁdence interval; AST, aspartate aminotransferase;
LDH, lactate dehydrogenase.
a Those factors found signiﬁcant (p < 0.05) in Table 3 were entered into a logistic
regression model to determine the independent contributors to MODS.
H. Li et al. / International Journal of Infectious Diseases 15 (2011) e859–e866e864being of advanced age, high creatinine, AST, and LDH levels,
disturbance of consciousness, and the presence of SIRS (Table 4 and
Figure 4). Based on the OR values, the risk factors for MODS in order
of decreasing magnitude were: disturbance of consciousness,
creatinine, AST, LDH, and age. Furthermore, the mortality of HGA
without MODS was 10.3% and with MODS was 64.0% (Figure 5).
Our results showed that there was an obvious difference in the
mortality, which was higher in the MODS group than in the non-
MODS group. Logistic regression identiﬁed MODS as an indepen-
dent predictor of death (OR 15.407, 95% CI 4.757–49.900; Wald
20.805; p < 0.001) (Figure 5).Figure 5. Bar chart showing the mortality rates in the non-MODS and MODS human
granulocytic anaplasmosis (HGA) groups, and correlation between MODS and death
(MODS, multiple organ dysfunction syndrome; OR, odds ratio; CI, conﬁdence
interval).4. Discussion
This report provides the ﬁrst clinical summary and outcome
analysis of HGA during the period 2009–2010 in the provinces of
Hubei and Henan in central China, a region in which the tick
vectors are prevalent. Currently the main Ixodes species in
mainland China is I. persulcatus. I. persulcatus is mainly distributed
in mountainous and hilly areas that are covered in rich vegetation;
its epidemic seasons are associated with times of peak larval
activity.7 In our study, the peak of the HGA outbreak occurred
during the months of May to August.
In our cohort, the majority of patients had a peasant occupation.
Most patients were resident in forest, mountain, and hilly regions
where the tick vectors are distributed. They lived in the countryside
and farmed in the ﬁelds, so they were at increased risk of being
exposed to the tick vectors. Physicians should be more alert for HGA
when attending to patients resident in speciﬁc geographic regions
where there are tick epidemics, especially during the summer
months.2
In our study, the median age of HGA patients was over 50 years;
older patients with HGA were in relatively poorer immune states,
which could have increased their susceptibility to infection.21,22 This
high median age may also have been a result of the tendency for the
majority of young people in China to travel away for work, leaving
just the elderly men and women to farm in the countryside.
Additional research on age trends in infection may assist physicians
in the accurate and timely diagnosis and treatment. We observed
that age was higher in those patients with HGA who died compared
with those who improved or recovered, suggesting that the
therapeutic effect is worse in older patients.
The transmission of HGA by means of contact with infectious
blood and secretions, and vertical and transfusion transmission
have been reported.4,6,23 There were no person-to-person trans-
missions in our hospital, because patient relatives were trained by
medical personnel to protect themselves with standard quarantine
practices.
In our study, the onset of HGA occurred 5–21 days after the
infected tick bite. This is consistent with other reports.24 The
clinical presentation of HGA in our hospital varied in severity from
a mild, self-limiting illness to death. Importantly, we found that a
high proportion of patients with HGA became critically ill; SIRS
accompanied HGA in 45.8% of patients, and 30.1% of patients
developed MODS following the diagnosis of HGA. These patients
were given the corresponding treatments once they had symptoms
of MODS. In our study, the median time from the onset of
symptoms to death was 25 days. These ﬁndings may provide useful
information so that physicians will be on the alert for severe
complications after a diagnosis with HGA and can optimize
supportive care for HGA-related critical illness. Prompt treatment
and close monitoring of the severe complications are of great
importance in saving patient lives.
Early diagnosis was paramount for effective treatment. In our
study, 61 patients were successfully treated with doxycycline, which
is recommended for the treatment of several rickettsial diseases.25,26
Most patients had an excellent clinical response and experienced
clinical improvement after prompt treatment. Follow-up of these
patients did not reveal any adverse sequelae. However recovery in
the event of multiple damaged organs when HGA was accompanied
by MODS was not easy, even when immediate therapy with
doxycycline and supportive treatment were given. Death occurred
within 1 week; ﬁve patients died on the day of hospital admission
and 17 cases were treated with doxycycline and comprehensive
therapy, but died of MODS at 4 days after hospital admission. This
indicates that it is of great importance to make an early diagnosis in
HGA and that empirical therapy with doxycycline should be used in
all patients suspected of having HGA.
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observed in patients within the USA and Europe.2,12 This raises the
question of why the HGA patients had more critical complications
and a higher mortality in China. One factor may be misdiagnosis
and delayed antibiotic therapy. HGA was ﬁrst reported in the
USA3,27 and Europe,28 and has only emerged recently in China.4 At
present, it is still not recognized by most Chinese doctors. The ﬁrst
case of HGA in our hospital was misdiagnosed as hemorrhagic
fever, because the clinical presentation of HGA bears some
resemblance to the syndrome commonly referred to as this
disease. Some patients admitted to the local hospital were
misdiagnosed with infections of the upper respiratory tract. With
a lack of precise understanding of the nature of this disease, some
patients in our cohort were transferred to the Department of
Infectious Diseases from the departments of respiration and
hematology. Diagnostic mistakes resulted in a progressive
deterioration in the patients’ conditions, until they were trans-
ferred to our hospital from the regional hospitals. To avoid
misdiagnoses in the future, physicians should improve their
recognition of HGA. Speciﬁcally, HGA should be considered in
patients who present with an acute febrile illness in regions where
HGA is endemic, particularly during the late spring and summer
months. If a patient is suspected of having HGA, not only should
laboratory tests be performed, but also empirical treatment with
doxycycline should be started immediately. These measures may
prevent the clinical course progressing to severe complications
such as MODS or death.
HGA seemed to present in an epidemic in China.6 This may due
to the variety of tick-borne ehrlichial agents and their tick vectors
in China.
In addition, SIRS accompanying HGA was noted on hospital
admission. SIRS occurred frequently in HGA patients, and the
number of SIRS criteria met had an inﬂuence on the clinical course.
In our study, there was a rapid progression to MODS in 55.3% (21/
38) of HGA patients with SIRS. Our results suggest that SIRS is a
harbinger of MODS in critically ill patients with HGA. The clinical
importance of SIRS has not been previously described in HGA. On
the basis of our ﬁndings, we propose a new concept – that SIRS may
play a critical role in inducing MODS in HGA patients in China.
From the standpoint of therapeutic intervention, it is important to
identify the signs of HGA with SIRS. Close monitoring of HGA
patients with SIRS who develop MODS may offer signiﬁcant
information for physicians so that they can deliver treatment
promptly; this may play an important role in saving patient lives.
We also identiﬁed some clinical and laboratory features at
presentation that were associated with MODS or death in patients
with HGA. In our cohort, the independent predictors of MODS and
an adverse outcome were an advanced age, high creatinine, AST,
and LDH levels, disturbance of consciousness, and SIRS during the
course of HGA. Although these laboratory markers are nonspeciﬁc,
patients were at very low risk of developing MODS or dying if these
laboratory markers recovered to normal levels within 48 h of
treatment. Finally, we identiﬁed MODS as an independent
predictor of death. These ﬁndings may provide useful information
so that physicians will be more aware of these laboratory markers
after a diagnosis of HGA in order to prevent HGA patients from
progressing to the MODS stage.
HGA is becoming a health hazard in China. Patients with HGA
were found to have more severe clinical symptoms, higher rates of
complications, particularly MODS, and higher mortality in China
than in Western countries. It is crucial to determine ways of
preventing the development of life-threatening complications
such as MODS and to reduce the mortality rate of this disease.
Avoiding exposure to ticks is the best method to prevent infection,
and early and appropriate therapy are key to signiﬁcantly reducing
the case fatality rate.Acknowledgements
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